| wsnewspublishers Terms of the Series A Convertible Preferred Stock and the common stock warrants are described in the Company’s current report on Form 8-K filed with the SEC on May 14, 2015. Nanosphere, Inc. develops, manufactures, and markets molecular diagnostic … |
